期刊
OCULAR IMMUNOLOGY AND INFLAMMATION
卷 17, 期 2, 页码 127-129出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/09273940802596559
关键词
etanercept; alopecia areata; inflammation
Purpose: To report a case of alopecia areata occurring during anti-tumor necrosis factor therapy. Methods: Observational case report. Results: The authors describe a 44-year-old man with ankylosing spondylitis who developed 6 months of patchy hair loss consistent with alopecia areata while undergoing treatment with etanercept. Conclusions: Although anti-TNF agents are expected to impede autoimmune-related processes such as alopecia areata, these drugs have been found to be causally related to the development of alopecia areata. Ophthalmologists who are increasing involved in using these biologic agents should be aware of possible side effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据